Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Iteos Therapeutics Inc (ITOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2019	12-2018	12-2017	12-2006	12-2005
Cash Flows From Operating Activities
Net Income	-22,454	-18,057	N/A	N/A	N/A
Depreciation Amortization	611	505	N/A	N/A	N/A
Accounts receivable	-4,854	-331	N/A	N/A	N/A
Accounts payable and accrued liabilities	-155	-133	N/A	N/A	N/A
Other Working Capital	-1,082	-1,856	N/A	N/A	N/A
Other Operating Activity	4,789	775	0	0	0
Operating Cash Flow	$-23,145	$-19,097	$N/A	$N/A	$N/A

Cash Flows From Investing Activities
Change In Deposits	-205	-73	N/A	N/A	N/A
PPE Investments	-721	-226	N/A	N/A	N/A
Investing Cash Flow	$-926	$-299	$N/A	$N/A	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	65	178	N/A	N/A	N/A
Common Stock Issued	102	N/A	N/A	N/A	N/A
Other Financing Activity	22,372	23,330	0	0	0
Financing Cash Flow	$22,539	$23,508	$N/A	$N/A	$N/A

Exchange Rate Effect	-532	-875	N/A	N/A	N/A
Beginning Cash Position	22,054	18,817	N/A	N/A	N/A
End Cash Position	19,990	22,054	N/A	N/A	N/A
Net Cash Flow	$-2,064	$3,237	$N/A	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-23,145	-19,097	N/A	N/A	N/A
Capital Expenditure	-721	-226	N/A	N/A	N/A
Free Cash Flow	-23,866	-19,323	0	0	0